Nationwide Fund Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-580,391
| Closed | -$10.2M | – | 1872 |
|
|
2017
Q3 | $10.2M | Sell |
580,391
-489,719
| -46% | -$8.62M | 0.04% | 630 |
|
|
2017
Q2 | $35.5M | Buy |
1,070,110
+67,675
| +7% | +$2.25M | 0.14% | 134 |
|
|
2017
Q1 | $32.2M | Sell |
1,002,435
-1,256
| -0.1% | -$40.3K | 0.13% | 165 |
|
|
2016
Q4 | $36.4M | Buy |
1,003,691
+37,266
| +4% | +$1.35M | 0.15% | 125 |
|
|
2016
Q3 | $44.5M | Sell |
966,425
-15,931
| -2% | -$733K | 0.19% | 90 |
|
|
2016
Q2 | $49.3M | Buy |
982,356
+117,506
| +14% | +$5.9M | 0.21% | 78 |
|
|
2016
Q1 | $46.5M | Buy |
864,850
+200,938
| +30% | +$10.8M | 0.2% | 87 |
|
|
2015
Q4 | $43.6M | Buy |
663,912
+91,200
| +16% | +$5.99M | 0.19% | 94 |
|
|
2015
Q3 | $32.3M | Buy |
572,712
+7,174
| +1% | +$405K | 0.15% | 140 |
|
|
2015
Q2 | $33.4M | Buy |
565,538
+12,224
| +2% | +$722K | 0.14% | 154 |
|
|
2015
Q1 | $34.5M | Buy |
553,314
+14,188
| +3% | +$884K | 0.14% | 152 |
|
|
2014
Q4 | $31M | Buy |
539,126
+24,666
| +5% | +$1.42M | 0.13% | 169 |
|
|
2014
Q3 | $27.7M | Buy |
514,460
+60,574
| +13% | +$3.26M | 0.12% | 194 |
|
|
2014
Q2 | $23.8M | Buy |
453,886
+109,247
| +32% | +$5.73M | 0.1% | 249 |
|
|
2014
Q1 | $18.2M | Sell |
344,639
-7,780
| -2% | -$411K | 0.08% | 297 |
|
|
2013
Q4 | $14.1M | Sell |
352,419
-48,355
| -12% | -$1.94M | 0.06% | 409 |
|
|
2013
Q3 | $15.1M | Buy |
400,774
+35,396
| +10% | +$1.34M | 0.07% | 357 |
|
|
2013
Q2 | $14.3M | Buy |
+365,378
| New | +$14.3M | 0.08% | 310 |
|